Search

Rodney K. Mintz

Examiner (ID: 875, Phone: (571)270-7327 , Office: P/3633 )

Most Active Art Unit
3633
Art Unit(s)
3633, 3635
Total Applications
1247
Issued Applications
978
Pending Applications
96
Abandoned Applications
217

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3873501 [patent_doc_number] => 05728387 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Structural gene of pneumococcal protein' [patent_app_type] => 1 [patent_app_number] => 8/214164 [patent_app_country] => US [patent_app_date] => 1994-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 4 [patent_no_of_words] => 4111 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728387.pdf [firstpage_image] =>[orig_patent_app_number] => 214164 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/214164
Structural gene of pneumococcal protein Mar 16, 1994 Issued
Array ( [id] => 4045290 [patent_doc_number] => 05874533 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'HIV-2 envelope polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/213416 [patent_app_country] => US [patent_app_date] => 1994-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 9932 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874533.pdf [firstpage_image] =>[orig_patent_app_number] => 213416 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/213416
HIV-2 envelope polypeptides Mar 14, 1994 Issued
08/213200 COMPOSITIONS AND METHODS FOR VACCINES COMPRISING ALPHA-GALACTOSYL EPITOPES Mar 14, 1994 Abandoned
Array ( [id] => 3717560 [patent_doc_number] => 05616688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)' [patent_app_type] => 1 [patent_app_number] => 8/207888 [patent_app_country] => US [patent_app_date] => 1994-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 15906 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616688.pdf [firstpage_image] =>[orig_patent_app_number] => 207888 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/207888
Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) Mar 6, 1994 Issued
08/207910 METHOD FOR ENHANCING THE ASSOCIATION OF EXOGENOUS PEPTIDES WITH CLASS I MHC MOLECULES ON THE SURFACE OF ANTIGEN PRESENTING CELLS WITH B-2 MICROGLOBULIN Mar 6, 1994 Abandoned
08/200744 THERAPEUTIC PREVENTIVE VACCINES FOR HIV Feb 22, 1994 Abandoned
Array ( [id] => 3700171 [patent_doc_number] => 05674705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Productive of human T-cell leukemia (lymphotropic) retrovirus (HTLV-1) envelope protein fragments in bacteria and use in seroepidemiological studies' [patent_app_type] => 1 [patent_app_number] => 8/194818 [patent_app_country] => US [patent_app_date] => 1994-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2200 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674705.pdf [firstpage_image] =>[orig_patent_app_number] => 194818 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/194818
Productive of human T-cell leukemia (lymphotropic) retrovirus (HTLV-1) envelope protein fragments in bacteria and use in seroepidemiological studies Feb 13, 1994 Issued
Array ( [id] => 3612556 [patent_doc_number] => 05510238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Production of human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein fragments in bacteria and use in seroepidemiological studies' [patent_app_type] => 1 [patent_app_number] => 8/193510 [patent_app_country] => US [patent_app_date] => 1994-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2127 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510238.pdf [firstpage_image] =>[orig_patent_app_number] => 193510 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/193510
Production of human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein fragments in bacteria and use in seroepidemiological studies Feb 6, 1994 Issued
Array ( [id] => 3759046 [patent_doc_number] => 05851813 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Primate lentivirus antigenic compositions' [patent_app_type] => 1 [patent_app_number] => 8/188583 [patent_app_country] => US [patent_app_date] => 1994-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 67 [patent_no_of_words] => 18729 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851813.pdf [firstpage_image] =>[orig_patent_app_number] => 188583 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/188583
Primate lentivirus antigenic compositions Jan 26, 1994 Issued
Array ( [id] => 3690990 [patent_doc_number] => 05660828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Method of treating autoimmune and/or viral-induced diseases that are mediated by CD8 phenotype T cells' [patent_app_type] => 1 [patent_app_number] => 8/177806 [patent_app_country] => US [patent_app_date] => 1994-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4356 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/660/05660828.pdf [firstpage_image] =>[orig_patent_app_number] => 177806 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/177806
Method of treating autoimmune and/or viral-induced diseases that are mediated by CD8 phenotype T cells Jan 5, 1994 Issued
08/178461 METHOD OF TREATING OR PREVENTING AUTOIMMUNE UVERORETINITIS IN MAMMALS Jan 5, 1994 Abandoned
Array ( [id] => 3700415 [patent_doc_number] => 05674720 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Design and construction of non-infectious human retroviral mutants deficient in genomic RNA' [patent_app_type] => 1 [patent_app_number] => 8/176682 [patent_app_country] => US [patent_app_date] => 1994-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8780 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674720.pdf [firstpage_image] =>[orig_patent_app_number] => 176682 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/176682
Design and construction of non-infectious human retroviral mutants deficient in genomic RNA Jan 2, 1994 Issued
08/171858 VACCINES BASED ON MEMBRANE BOUND PROTEINS AND PROCESS FOR MAKING THEM Dec 20, 1993 Abandoned
Array ( [id] => 3660260 [patent_doc_number] => 05591823 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Expression of specific immunogens using viral antigens' [patent_app_type] => 1 [patent_app_number] => 8/169813 [patent_app_country] => US [patent_app_date] => 1993-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8817 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591823.pdf [firstpage_image] =>[orig_patent_app_number] => 169813 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/169813
Expression of specific immunogens using viral antigens Dec 16, 1993 Issued
Array ( [id] => 3690701 [patent_doc_number] => 05691448 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome' [patent_app_type] => 1 [patent_app_number] => 8/161290 [patent_app_country] => US [patent_app_date] => 1993-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15667 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691448.pdf [firstpage_image] =>[orig_patent_app_number] => 161290 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/161290
Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome Dec 1, 1993 Issued
Array ( [id] => 3720265 [patent_doc_number] => 05681556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Method and compositions for suppressing allograft rejection in mammals' [patent_app_type] => 1 [patent_app_number] => 8/159044 [patent_app_country] => US [patent_app_date] => 1993-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7134 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681556.pdf [firstpage_image] =>[orig_patent_app_number] => 159044 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/159044
Method and compositions for suppressing allograft rejection in mammals Nov 28, 1993 Issued
Array ( [id] => 3623074 [patent_doc_number] => 05688914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus' [patent_app_type] => 1 [patent_app_number] => 8/150249 [patent_app_country] => US [patent_app_date] => 1993-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8156 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688914.pdf [firstpage_image] =>[orig_patent_app_number] => 150249 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/150249
Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus Nov 8, 1993 Issued
08/145664 INDUCTION OF PROTECTION AGAINST VIRAL INFECTION BY SYNERGY BETWEEN VIRUS ENVELOPE GLYCOPROTEIN AND PEPTIDES CORRESPONDING TO NEUTRALIZATION EPITOPES OF THE GLYCOPROTEIN Nov 3, 1993 Abandoned
08/143577 INHIBITION OF HIV MUCOSAL BINDING Oct 25, 1993 Abandoned
Array ( [id] => 3993480 [patent_doc_number] => 05858366 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding' [patent_app_type] => 1 [patent_app_number] => 8/135312 [patent_app_country] => US [patent_app_date] => 1993-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11858 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858366.pdf [firstpage_image] =>[orig_patent_app_number] => 135312 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/135312
Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding Oct 11, 1993 Issued
Menu